Volume : 10, Issue : 03, March – 2023
Title:
35.FORMULATION & EVALUATION OF ALMOTRIPTAN ORAL DISINTEGRATING TABLETS
Authors :
Karan Singh, Lalit Kumar
Abstract :
Oral disintegration tablets are the novel technology for administration of the drug through the oral route. The tablet is the most widely used dosage form because of its convenience in terms of self -administration, compactness and ease in manufacturing. Oral Disintegrating tablets have been found to be the choice for Psychiatric as well as patient suffering from stroke, thyroid disorder, Parkinson’s diseases and multiple sclerosis, patients with nausea, vomiting and motion sickness. ODTs may Show increased oral bioavailability, good stability, accurate dosing, easy manufacturing, small packaging size, and easy to handle by patients.This research paper is about to formulation & evaluation of almotriptan oral disintegrating tablets.
Keywords:Disintegration,compactness, bioavailability, stability.
Cite This Article:
Please cite this article in press Karan Singh et al,Formulation & Evaluation Of Almotriptan Oral Disintegrating Tablets.,Indo Am. J. P. Sci, 2023; 10(03).
Number of Downloads : 10
References:
[1]. Ashish P, Harsoliya MS, Pathan JK, Shruti S. A review – Formulation of mouthdissolvingtablet.InternationalJournalofPharmacologyandClinicalSciences2011;1(1):1-8.
[2]. AkulaNikhilPrashant,J.SharmaV.C,NagarajuPotnuriandSrinivasMartha.Formulation and evaluation of oral disintegratingtablets of Nateglinide. ScholarsResearchLibraryDer Pharmacia Lettre, 2015; 7 (2):49-59.
[3]. Bhupendra G, Prajapati, Bhaskar Patel., International Journal of Pharm Tech Research, Vol.2, No.3, pp 1893-1899.
[4]. Brown D, Orally disintegrating tablets: Taste over speed. Drug Deliv Tech, 2001; 3(6): 58-61.
[5]. Brown D. Orally disintegrating tablets – taste over speed. Drug Deliv Technol 2003; 3:58-61.
[6]. Behnke K, Sogaard J, Martin S, Bauml J, Ravindran AV, Agren H, et al. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Journal of Clinical Psychopharmacology 2003; 23(4):358-364.
[7]. Balakrishna T, Vidyadhara S, Murthy T. E. G. K, Viswanadh K, Tejasri M. Formulation and evaluation of Oro dispersible tablets of Zolmitriptan. Asian Journal of Pharmaceutics, 2016; 10 (4): 683-687.
[8]. Bradoo R, Shahani S, Deewan B, Sudarshan S. Fast dissolving drug delivery system. J Am Med Assoc India, 2001; 4 (10): 27-31.